Replicating Vesicular Stomatitis Virus Vectors ( VSV ) Expressing Membrane - Anchored MPER Immunogens
نویسندگان
چکیده
lactide)-b-poly (N-vinylpyrrolidone-co-N-acryloxysuccinimide) (PLA-b-P (NVP-co-NAS), 19000–22000 g.mol 1, PDI= 1.5) were prepared by nanoprecipitation and characterized in terms of size (DLS) and critical micellar concentration (cmc). Imiquimod was incubated with the aqueous micellar solution for 1 hour and imiquimod loading in the micelles was quantified by fluorimetry. The micelles were further surface functionalized p24 antigen, through amine reaction with the N-succinimidyl esters of the NAS units at micelle surface in PBS pH 7.4 for 20 hours. Protein coupling on the micelles were investigated by SDS-PAGE. The expression of DC maturation/activation markers CD80, CD83, CD86 induced by the micelles was assessed in vitro by flow cytometry. Results: The micelles initially prepared from the PLA-b-P(NVPco-NAS) copolymer exhibited a mean diameter of 58 nm and a CMC of 20mg.mL 1 . Hydrophobic imiquimod was encapsulated at a loading of 1.5% (w/w). The imiquimod-loaded micelles were further highly surface-functionalized with p24 antigen, at a level of 0.12mg p24 per mg of micelle, with a final size of 110 nm. Imiquimod encapsulated in the micelles was shown to induce up-regulation of the DC maturation markers. Conclusion: Such novel micelle-based systems could thus be promising for vaccine delivery, particularly considering their ability to potentially reach DCs in the lymph nodes, due to their small size ( < 120 nm).
منابع مشابه
A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector.
Live attenuated vaccine vectors based on recombinant vesicular stomatitis virus (VSV) are effective in several viral disease models. In this study, we asked if a VSV vector capable of only a single cycle of replication might be an effective alternative to replication-competent VSV vectors. We compared the cellular immune responses to human immunodeficiency virus (HIV) envelope protein (Env) exp...
متن کاملVaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
Previously, recombinant vesicular stomatitis virus (rVSV) pseudotypes expressing Ebolavirus glycoproteins (GPs) in place of the VSV G protein demonstrated protection of nonhuman primates from lethal homologous Ebolavirus challenge. Those pseudotype vectors contained no additional attenuating mutations in the rVSV genome. Here we describe rVSV vectors containing a full complement of VSV genes an...
متن کاملProperties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.
Replication-competent recombinant vesicular stomatitis viruses (rVSVs) expressing the type I transmembrane glycoproteins and selected soluble glycoproteins of several viral hemorrhagic fever agents (Marburg virus, Ebola virus, and Lassa virus) were generated and characterized. All recombinant viruses exhibited rhabdovirus morphology and replicated cytolytically in tissue culture. Unlike the rVS...
متن کاملAttenuated vesicular stomatitis viruses as vaccine vectors.
We showed previously that a single intranasal vaccination of mice with a recombinant vesicular stomatitis virus (VSV) expressing an influenza virus hemagglutinin (HA) protein provided complete protection from lethal challenge with influenza virus (A. Roberts, E. Kretzschmar, A. S. Perkins, J. Forman, R. Price, L. Buonocore, Y. Kawaoka, and J. K. Rose, J. Virol. 72:4704-4711, 1998). Because some...
متن کاملUse of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes.
Influenza C virus contains two envelope glycoproteins: CM2, a putative ion channel protein; and HEF, a unique multifunctional protein that performs receptor-binding, receptor-destroying and fusion activities. Here, it is demonstrated that expression of HEF is sufficient to pseudotype replication-incompetent vesicular stomatitis virus (VSV) that lacks the VSV glycoprotein (G) gene. The pseudotyp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2013